Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis Eero O. Honkanen, Anna-Maija Teppo, Carola.

Slides:

Advertisements

Similar presentations

Volume 81, Issue 2, Pages (January 2012)

Advertisements

Volume 74, Issue 12, Pages (December 2008)

Volume 70, Issue 10, Pages (November 2006)

A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use Mei-Ling Blank, Lianne.

Volume 65, Issue 6, Pages (June 2004)

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Volume 67, Issue 6, Pages (June 2005)

Volume 86, Issue 6, Pages (December 2014)

Membranous nephropathy: When and how to treat

Reassessment of the care of the patient with chronic kidney disease

Volume 74, Issue 12, Pages (December 2008)

Volume 80, Issue 10, Pages (November 2011)

Volume 53, Issue 4, Pages (April 1998)

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

Volume 84, Issue 2, Pages (August 2013)

Kumar Sharma, Ljiljana Paša-Tolić Kidney International

Managing Rare CKDs.

Rutger J.H. Maas, Jack F.M. Wetzels, Jeroen K.J. Deegens

Steven J. Chadban, Natalie D. Staplin Kidney International

Serum-soluble urokinase receptor concentration in primary FSGS

Volume 54, Issue 4, Pages (October 1998)

Volume 74, Issue 3, Pages (August 2008)

Proinflammatory effects of iron sucrose in chronic kidney disease

Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot? Bertram L. Kasiske, MD American Journal of Kidney.

Volume 78, Issue 5, Pages (September 2010)

Volume 57, Issue 1, Pages (January 2000)

The role of protein kinase C activation in diabetic nephropathy

Volume 55, Issue 2, Pages (February 1999)

Volume 73, Issue 11, Pages (June 2008)

Tarak Srivastava, Robert E. Garola, Joan M. Whiting, Uri S. Alon

Volume 85, Issue 3, Pages (March 2014)

Synaptopodin expression in idiopathic nephrotic syndrome of childhood

Volume 61, Issue 1, Pages (January 2002)

Volume 69, Issue 12, Pages (June 2006)

HIV-related nephropathy: A South African perspective

Volume 72, Issue 12, Pages (December 2007)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Shining a LAMP on pauci-immune focal segmental glomerulonephritis

Methods for guideline development

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 67, Issue 4, Pages (April 2005)

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

The initiation and progression of sickle cell nephropathy

Juan Camilo Duque, Roberto I. Vazquez-Padron Kidney International

Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen

Volume 71, Issue 4, Pages (February 2007)

Volume 60, Issue 1, Pages (July 2001)

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

Volume 82, Issue 9, Pages (November 2012)

Volume 65, Issue 6, Pages (June 2004)

Phosphate binders on iron basis: A new perspective?

Volume 55, Pages S3-S16 (June 1999)

Volume 80, Issue 10, Pages (November 2011)

Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity Lorenzo.

Volume 72, Issue 11, Pages (December 2007)

Is it the low-protein diet or simply the salt restriction?

Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular.

Volume 71, Issue 9, Pages (May 2007)

MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis Antonio Guasch, M.D., Carlos F. Zayas, Kamal.

Volume 62, Issue 5, (November 2002)

Membranous nephropathy: recent travels and new roads ahead

Volume 53, Issue 5, Pages (May 1998)

Volume 74, Issue 10, Pages (November 2008)

Volume 56, Issue 6, Pages (December 1999)

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases Martina Franz, Wolfgang Woloszczuk,

Epidemiologic data of primary glomerular diseases in western France

Letter from W. Lornoy; I. Becaus; J.M. Billiouw and L. Sierens

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis Eero O. Honkanen, Anna-Maija Teppo, Carola Grönhagen-Riska Kidney International Volume 57, Issue 6, Pages 2343-2349 (June 2000) DOI: 10.1046/j.1523-1755.2000.00094.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Urinary vascular endothelial growth factor (VEGF) excretion in different glomerular diseases and healthy control subjects. Abbreviations are: MGN, membranous glomerulonephritis; MC, minimal change glomerulonephritis; FSGS, focal segmental glomerulosclerosis; VAS, vasculitis; DNP, diabetic nephropathy; Control, healthy controls. The lines indicate the mean values for each group. Kidney International 2000 57, 2343-2349DOI: (10.1046/j.1523-1755.2000.00094.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Patients with improving membranous glomerulonephritis. Changes in urinary protein (A) and VEGF (B) excretion over one year. Kidney International 2000 57, 2343-2349DOI: (10.1046/j.1523-1755.2000.00094.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Patients with persistent membranous glomerulonephritis. Changes in urinary protein (A) and VEGF (B) excretion over one year. Kidney International 2000 57, 2343-2349DOI: (10.1046/j.1523-1755.2000.00094.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Correlation between the change in urinary protein excretion (α proteinuria) and VEGF excretion (α urinary VEGF) during a one-year follow-up (r = 0.57; P < 0.026). Kidney International 2000 57, 2343-2349DOI: (10.1046/j.1523-1755.2000.00094.x) Copyright © 2000 International Society of Nephrology Terms and Conditions